Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017 (2017), Article ID 8394732, 5 pages
https://doi.org/10.1155/2017/8394732
Case Report

A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification—A Case Study on Sickle Cell Disease

1Oncology, Hematology, and Bioethical Committee, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
2Oncology and Hematology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
3Hematology and Bone Marrow Transplantation, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
4Bioethical Committee, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Correspondence should be addressed to Andrea Z. Pereira

Received 21 October 2016; Revised 30 January 2017; Accepted 13 February 2017; Published 23 February 2017

Academic Editor: Kostas Konstantopoulos

Copyright © 2017 Andrea Z. Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bhatia and S. Sheth, “Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations,” Journal of Blood Medicine, vol. 6, pp. 229–238, 2015. View at Publisher · View at Google Scholar
  2. R. S. Nickel, J. E. Hendrickson, and A. E. Haight, “The ethics of a proposed study of hematopoietic stem cell transplant for children with ‘less severe’ sickle cell disease,” Blood, vol. 124, no. 6, pp. 861–866, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. W. Chan, “Hematopoietic stem cell transplantation for sickle cell disease: more options and many unanswered questions,” Journal of Blood Disorders & Transfusion, vol. 3, no. 6, 2012. View at Publisher · View at Google Scholar
  4. A. Chybicka, “Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure,” Bone Marrow Transplantation, vol. 42, supplement 2, pp. S87–S89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Walters, M. Patience, W. Leisenring et al., “Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia,” Biology of Blood and Marrow Transplantation, vol. 7, no. 12, pp. 665–673, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. de Montalembert and I. Roberts, “Sickle cell disease: primum non nocere (first do no harm),” Haematologica, vol. 95, no. 1, pp. 4–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Shenoy, “Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions,” Therapeutic Advances in Hematology, vol. 4, no. 5, pp. 335–344, 2013. View at Publisher · View at Google Scholar
  8. M. M. Hsieh, C. D. Fitzhugh, and J. F. Tisdale, “Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now,” Blood, vol. 118, no. 5, pp. 1197–1207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shenoy, “Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends,” Hematology. American Society of Hematology. Education Program, vol. 2011, pp. 273–279, 2011. View at Google Scholar · View at Scopus
  10. F. Bernaudin, G. Socie, M. Kuentz et al., “Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease,” Blood, vol. 110, no. 7, pp. 2749–2756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Hsieh, C. D. Fitzhugh, R. P. Weitzel et al., “Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype,” The Journal of the American Medical Association, vol. 312, no. 1, pp. 48–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Krishnamurti, S. Abel, M. Maiers, and S. Flesch, “Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies,” Bone Marrow Transplantation, vol. 31, no. 7, pp. 547–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. I. Pestina, P. W. Hargrove, H. Zhao et al., “Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells,” Molecular Therapy - Methods & Clinical Development, vol. 2, article 15045, 2015. View at Publisher · View at Google Scholar
  14. A. A. Kassim, N. A. Galadanci, S. Pruthi, and M. R. DeBaun, “How I treat and manage strokes in sickle cell disease,” Blood, vol. 125, no. 22, pp. 3401–3410, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-J. Chang, C.-L. Weng, L.-X. Sun, and Y.-T. Zhao, “Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials,” Annals of Hematology, vol. 91, no. 3, pp. 427–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Bacigalupo, J. Tong, M. Podesta et al., “Bone marrow harvest for marrow transplantation: effect of multiple small (2 ml) or large (20 ml) aspirates,” Bone Marrow Transplantation, vol. 9, no. 6, pp. 467–470, 1992. View at Google Scholar · View at Scopus
  17. H. Lannert, T. Able, S. Becker et al., “Optimizing BM harvesting from normal adult donors,” Bone Marrow Transplantation, vol. 42, no. 7, pp. 443–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Miller, E. H. Perry, T. H. Price et al., “Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program,” Biology of Blood and Marrow Transplantation, vol. 14, no. 9, supplement, pp. 29–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Pulsipher, P. Chitphakdithai, B. R. Logan et al., “Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program,” Blood, vol. 121, no. 1, pp. 197–206, 2013. View at Google Scholar
  20. D. F. Stroncek, P. V. Holland, G. Bartch et al., “Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program,” Blood, vol. 81, no. 7, pp. 1940–1946, 1993. View at Google Scholar · View at Scopus
  21. S. A. M. McLean, “What and who are clinical ethics committees for?” Journal of Medical Ethics, vol. 33, no. 9, pp. 497–500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Bitan, S. M. van Walraven, N. Worel et al., “Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations. recommendations from a working group of the worldwide network for blood and marrow transplantation association,” Biology of Blood and Marrow Transplantation, vol. 22, no. 1, pp. 96–103, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. K. D. MacLeod, S. F. Whitsett, E. J. Mash, and W. Pelletier, “Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience,” Journal of Pediatric Psychology, vol. 28, no. 4, pp. 223–230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. D. Pentz, A. E. Haight, R. B. Noll et al., “The ethical justification for minor sibling bone marrow donation: a case study,” Oncologist, vol. 13, no. 2, pp. 148–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Bendorf and I. H. Kerridge, “Ethical issues in bone marrow transplantation in children,” Journal of Paediatrics and Child Health, vol. 47, no. 9, pp. 614–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. S. Wiener, E. Steffen-Smith, T. Fry, and A. S. Wayne, “Hematopoietic stem cell donation in children: a review of the sibling donor experience,” Journal of Psychosocial Oncology, vol. 25, no. 1, pp. 45–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. American Academy of Pediatrics and Committee on Bioethics, “Children as hematopoietic stem cell donors,” Pediatrics, vol. 125, no. 2, pp. 392–404, 2010. View at Google Scholar
  28. M. A. Pulsipher, “A donor's a person, no matter how small,” Blood, vol. 119, no. 12, pp. 2705–2706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G. R. Burgio, L. Nespoli, R. Maccario, A. Verri, P. Comoli, and M. Zecca, “Conceiving a hematopoietic stem cell donor: twenty-five years after our decision to save a child,” Haematologica, vol. 97, no. 4, pp. 479–481, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. L. F. Ross, “In defense of the american academy of pediatrics policy statement—children as hematopoietic stem cell donors,” Pediatric Blood and Cancer, vol. 56, no. 4, pp. 520–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. L. Beauchamp, “Methods and principles in biomedical ethics,” Journal of Medical Ethics, vol. 29, no. 5, pp. 269–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. L. Beauchamp and J. F. Childress, Principles of Biomedical Ethics, Oxford University Press, Oxford, UK, 5th edition, 2000.
  33. G. R. Burgio and F. Locatelli, “Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethics,” Bone Marrow Transplantation, vol. 19, no. 12, pp. 1163–1168, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Caocci, G. La Nasa, E. D'Aloja et al., “Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients,” BMC Medical Ethics, vol. 12, no. 1, article no. 4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Thomas, “Bioethics consultations and resources,” Ochsner Journal, vol. 11, no. 4, pp. 357–359, 2011. View at Google Scholar · View at Scopus
  36. E. J. Emanuel, D. Wendler, and C. Grady, “What makes clinical research ethical?” The Journal of the American Medical Association, vol. 283, no. 20, pp. 2701–2711, 2000. View at Publisher · View at Google Scholar · View at Scopus